Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
Clinical trial NCT04108104 · COMPLETED
Trial details
- NCT number
- NCT04108104
- Sponsor
- Kinnov Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-30
- Primary completion
- 2021-10-28
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.